Lisa Deschamps - Nov 2, 2021 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role
Director
Signature
/s/ Claire Poll, Attorney-in-fact for Lisa Deschamps
Stock symbol
VRNA
Transactions as of
Nov 2, 2021
Transactions value $
-$7,690
Form type
4
Date filed
11/3/2021, 07:53 PM
Previous filing
Aug 10, 2021
Next filing
Feb 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRNA Ordinary Shares Sale -$7.69K -11.7K -12.46% $0.66* 82K Nov 2, 2021 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2 The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported Restricted Share Units.
F3 The price reported represents the sale price of the Issuer's ADSs divided by eight (8).
F4 Consists of (i) 29,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 3,625 ADSs); and (ii) 52,984 Ordinary Shares underlying 6,623 ADSs.